新規登録 | ログイン | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

jyuh Matsui [15 articles]

最近 jyuh さんのライブラリに追加された論文の中から 著者が Matsui. であるものをリストアップしています. You can also see everyone's Matsui.
  • Rapid induction of peroxisome proliferator-activated receptor gamma expression in human monocytes by monosodium urate monohydrate crystals.
    Arthritis and rheumatism, Vol. 48, No. 1. (January 2003), pp. 231-239.
    posted to pparg gout by jyuh on 2008-08-17 06:12:02 as **
  • Quantitative evaluation of the diagnostic thinking process in medical students.
    Journal of general internal medicine : official journal of the Society for Research and Education in Primary Care Internal Medicine, Vol. 17, No. 11. (November 2002), pp. 839-844.
    by Y Noguchi, K Matsui, H Imura, M Kiyota, T Fukui
    posted to diagnosis by jyuh on 2008-07-15 07:20:09 as **
  • A traditionally administered short course failed to improve medical students' diagnostic performance. A quantitative evaluation of diagnostic thinking.
    J Gen Intern Med, Vol. 19, No. 5 Pt 1. (May 2004), pp. 427-432.
    by Y Noguchi, K Matsui, H Imura, M Kiyota, T Fukui
  • Sample Size Calculations Based on Ranking and Selection in Microarray Experiments
    Biometrics, Vol. 64, No. 1. (March 2008), pp. 217-226.
    posted to power microarray by jyuh on 2008-03-04 12:19:09 as ** along with 1 person jfr
  • Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression.
    Microvasc Res, Vol. 75, No. 1. (January 2008), pp. 130-134.
    posted to no-tag by jyuh on 2008-01-16 02:07:30 as **
  • Oral administration of AST-120 (Kremezin) is a promising therapeutic strategy for advanced glycation end product (AGE)-related disorders.
    Med Hypotheses, Vol. 69, No. 3. (2007), pp. 666-668.
    posted to no-tag by jyuh on 2008-01-14 12:00:24 as **
  • Serum cystatin C in diabetic patients Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
    Diabetes Res Clin Pract (1 November 2007)
    by Yoshiji Ogawa, Takashi Goto, Naoki Tamasawa, Jun Matsui, Yusuke Tando, Kazuhiro Sugimoto, Ken Tomotsune, Masahiko Kimura, Minoru Yasujima, Toshihiro Suda
    posted to no-tag by jyuh on 2007-11-15 03:20:28 as **
  • Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation.
    Diabetologia, Vol. 49, No. 12. (December 2006), pp. 3094-3099.
    posted to no-tag by jyuh on 2007-10-23 10:12:47 as **
  • Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension.
    Microvasc Res, Vol. 70, No. 3. (November 2005), pp. 137-141.
    posted to no-tag by jyuh on 2007-10-23 10:09:10 as **
  • Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-induced monocyte chemoattractant protein-1 expression in mesangial cells through downregulation of receptor for AGEs via peroxisome proliferator-activated receptor-gamma activation.
    J Int Med Res, Vol. 35, No. 4. (g 2007), pp. 482-489.
    posted to no-tag by jyuh on 2007-10-23 10:08:26 as **
  • Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance
    Nat Med, Vol. 13, No. 10. (October 2007), pp. 1193-1202.
    by Takashi Matsuzaka, Hitoshi Shimano, Naoya Yahagi, Toyonori Kato, Ayaka Atsumi, Takashi Yamamoto, Noriyuki Inoue, Mayumi Ishikawa, Sumiyo Okada, Naomi Ishigaki, Hitoshi Iwasaki, Yuko Iwasaki, Tadayoshi Karasawa, Shin Kumadaki, Toshiyuki Matsui, Motohiro Sekiya, Ken Ohashi, Alyssa H Hasty, Yoshimi Nakagawa, Akimitsu Takahashi, Hiroaki Suzuki, Sigeru Yatoh, Hirohito Sone, Hideo Toyoshima, Jun-Ichi Osuga, Nobuhiro Yamada
    posted to no-tag by jyuh on 2007-10-07 06:09:02 as **
  • Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.
    Diabetes Metab Res Rev (10 August 2007)
    by Kazuo Nakamura, Sho-Ichi I Yamagishi, Hisashi Adachi, Takanori Matsui, Yayoi Kurita-Nakamura, Masayoshi Takeuchi, Hiroyoshi Inoue, Tsutomu Imaizumi
    posted to no-tag by jyuh on 2007-09-14 03:06:16 as **
  • Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease.
    Diabetes Metab Res Rev, Vol. 23, No. 5. (July 2007), pp. 368-371.
    posted to no-tag by jyuh on 2007-09-14 03:05:18 as **
  • Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes.
    Mol Med, Vol. 13, No. 3-4. (r 2007), pp. 185-189.
    posted to no-tag by jyuh on 2007-09-14 03:04:32 as **
  • Reversible Smad-dependent signaling between tumor suppression and oncogenesis.
    Cancer Res, Vol. 67, No. 11. (1 June 2007), pp. 5090-5096.
    posted to no-tag by jyuh on 2007-07-13 07:53:28 as **
  • 注: このページを引用する時は次のURLでどうぞ: http://www.citeulike.org/user/jyuh/author/Matsui

    RIS BibTeX